New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
17:45 EDTTEVA, BIIBTeva files FDA petition to review safety of Biogen MS drug, Reuters reports
Teva (TEVA) has filed a petition with the FDA that asks the agency to have an outside panel evaluate the safety of Biogen's (BIIB) multiple sclerosis drug, BG-12, before approval, and if the FDA review is granted the drug's launch could be delayed, according to a Reuters report. Reference Link
News For TEVA;BIIB From The Last 14 Days
Check below for free stories on TEVA;BIIB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
07:26 EDTBIIBInforma Business Information to hold a conference
Subscribe for More Information
07:19 EDTTEVAUBS to hold a field trip
Subscribe for More Information
05:26 EDTTEVAProtalix appoints Moshe Manor as CEO
Subscribe for More Information
September 22, 2014
07:21 EDTBIIBEBD Group to hold a conference
Subscribe for More Information
September 17, 2014
11:01 EDTTEVAActavis drops after NY AG seeks to block Alzheimer drug switch
Subscribe for More Information
08:05 EDTTEVAEagle Pharm says Teva requests motion to dismiss Bendamustine lawsuit
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use